Previously published work has used EVs to assess changes in biomarkers of brain insulin signaling in clinical trials of a protein restriction diet for prostate cancer [30], exenatide for PD [21], and intranasal insulin for AD [29]. This evidence concerns the gene INS and Familial prostate cancer.